Interplay between receptor tyrosine kinases and hypoxia signaling in cancer
- PMID: 25747905
- DOI: 10.1016/j.biocel.2015.02.018
Interplay between receptor tyrosine kinases and hypoxia signaling in cancer
Abstract
Deregulated signaling via receptor tyrosine kinase (RTK) pathways is prevalent in numerous types of human cancers and is commonly correlated with worst prognosis, resistance to various treatment modalities and increased mortality. Likewise, hypoxic tumors are often manifested by aggressive mode of growth and progression following an adaptive genetic reprogramming with consequent transcriptional activation of genes encoding proteins, which support tumor survival under low oxygen-related conditions. Consequently, both the hypoxia-inducible factor (HIF) system, which is the major mediator of hypoxia-related signaling, and numerous RTK systems are considered critical molecular targets in current cancer therapy. It is now evident that there is an intricate molecular crosstalk between RTKs and hypoxia-related signaling in the sense that hypoxia can activate expression of particular RTKs and/or their corresponding ligands, while some RTK systems have been shown to trigger activation of the HIF machinery. Moreover, signaling regulation of some RTK systems under hypoxic conditions has also been documented to take place in a HIF-independent manner. With this review we aim at overviewing the most current observations on that topic and highlight the importance of the potential co-drugging the HIF system along with particular relevant RTKs for better tumor growth control.
Keywords: Cancer; HIF system; Hypoxia; RTKs; VEGF.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Similar articles
-
Androgens stimulate hypoxia-inducible factor 1 activation via autocrine loop of tyrosine kinase receptor/phosphatidylinositol 3'-kinase/protein kinase B in prostate cancer cells.Clin Cancer Res. 2003 Jul;9(7):2416-25. Clin Cancer Res. 2003. PMID: 12855613
-
HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression.Mol Cell Biol. 2001 Jun;21(12):3995-4004. doi: 10.1128/MCB.21.12.3995-4004.2001. Mol Cell Biol. 2001. PMID: 11359907 Free PMC article.
-
The role of the hypoxia-inducible factor in tumor metabolism growth and invasion.Bull Cancer. 2006 Aug;93(8):E73-80. Bull Cancer. 2006. PMID: 16935775 Review.
-
Hypoxia-inducible factor-1 in human breast and prostate cancer.Endocr Relat Cancer. 2006 Sep;13(3):739-49. doi: 10.1677/erc.1.00728. Endocr Relat Cancer. 2006. PMID: 16954428 Review.
-
Does endogenous fatty acid metabolism allow cancer cells to sense hypoxia and mediate hypoxic vasodilatation? Characterization of a novel molecular connection between fatty acid synthase (FAS) and hypoxia-inducible factor-1alpha (HIF-1alpha)-related expression of vascular endothelial growth factor (VEGF) in cancer cells overexpressing her-2/neu oncogene.J Cell Biochem. 2005 Apr 1;94(5):857-63. doi: 10.1002/jcb.20367. J Cell Biochem. 2005. PMID: 15669079
Cited by
-
Characterizing the Hot Spots Involved in RON-MSPβ Complex Formation Using In Silico Alanine Scanning Mutagenesis and Molecular Dynamics Simulation.Adv Pharm Bull. 2017 Apr;7(1):141-150. doi: 10.15171/apb.2017.018. Epub 2017 Apr 13. Adv Pharm Bull. 2017. PMID: 28507948 Free PMC article.
-
Encircling the regions of the pharmacogenomic landscape that determine drug response.Genome Med. 2019 Mar 26;11(1):17. doi: 10.1186/s13073-019-0626-x. Genome Med. 2019. PMID: 30914058 Free PMC article.
-
Recent Advances on the Role of G Protein-Coupled Receptors in Hypoxia-Mediated Signaling.AAPS J. 2016 Mar;18(2):305-10. doi: 10.1208/s12248-016-9881-6. Epub 2016 Feb 10. AAPS J. 2016. PMID: 26865461 Free PMC article. Review.
-
Progress toward overcoming hypoxia-induced resistance to solid tumor therapy.Cancer Manag Res. 2015 Aug 12;7:253-64. doi: 10.2147/CMAR.S58285. eCollection 2015. Cancer Manag Res. 2015. PMID: 26316817 Free PMC article. Review.
-
Uncoupling protein 2 downregulation by hypoxia through repression of peroxisome proliferator-activated receptor γ promotes chemoresistance of non-small cell lung cancer.Oncotarget. 2017 Jan 31;8(5):8083-8094. doi: 10.18632/oncotarget.14097. Oncotarget. 2017. PMID: 28042952 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources